Director of the Department at Shanghai Pudong Hospital, China
Ligang Zhou is a distinguished endocrinologist and researcher, serving as the Chief Physician and Director of Endocrinology and International Medical Department at Shanghai Pudong Hospital, affiliated with Fudan University. With extensive experience in neuroendocrinology and metabolic disorders, he has made significant contributions to diabetes research and treatment innovations. He chairs the Pudong Endocrinology Committee, actively participates in multiple professional organizations, and has published extensively in top-tier scientific journals. His commitment to advancing endocrinology and integrative medicine has earned him recognition in both research and clinical practice.
profile
orcid
Education
Ligang Zhou completed his medical degree at Tianjin Medical University in 1991. He pursued a PhD in Neuroendocrinology from Kyoto University in 2004, focusing on the intricate mechanisms regulating metabolic disorders. To further refine his expertise, he undertook postdoctoral research at the University of Cambridge and Yale University, where he specialized in translational endocrinology and diabetes-related complications. His rigorous academic training has enabled him to bridge fundamental research with clinical applications, significantly impacting endocrine disease management.
Experience
With over three decades of experience in endocrinology, Dr. Zhou has held leadership roles in Shanghai Pudong Hospital, spearheading clinical advancements and research initiatives. He has led numerous national and international projects, including collaborations with prestigious institutions such as Fudan University and Shanghai Jiaotong University. His expertise extends to consultancy roles with the Shanghai Association for Science and Technology and Jiusan Society. As an editor for Springer Nature and BMC journals, he contributes to the dissemination of cutting-edge endocrinology research.
Research Interests
Dr. Zhou’s research primarily focuses on endocrinology, neuroendocrinology, obesity, diabetes, and its complications. His investigations delve into the role of GLP-1, GIP, and SGLT-2 in metabolic disorders. He has played a pivotal role in improving hierarchical diagnosis and treatment strategies, particularly in Shanghai’s Nanhui community. His research has advanced diagnostic methodologies, including the early detection of latent autoimmune diabetes, significantly enhancing local healthcare standards.
Awards
Dr. Zhou has received numerous accolades for his contributions to endocrinology and diabetes research. His dedication to advancing clinical practice and academic knowledge has led to recognition from prestigious medical organizations. He has also been a recipient of grants such as the “Pujiang Talent Fund” and the “Oriental Scholar” award, emphasizing his impact on endocrine research and patient care.
Selected Publications
Zhou, L. et al. (2023). “Advances in GLP-1 receptor agonists for type 2 diabetes.” Diabetes Obesity and Metabolism. [Cited by 120]
Zhou, L. et al. (2021). “Neuroendocrine regulation of metabolic disorders: Insights from animal models.” Endocrinology. [Cited by 95]
Zhou, L. et al. (2019). “Role of SGLT-2 inhibitors in diabetes management.” Journal of Translational Medicine. [Cited by 85]
Zhou, L. et al. (2018). “Mechanisms of insulin resistance in obesity-related diabetes.” Cell Metabolism. [Cited by 110]
Zhou, L. et al. (2017). “Integration of Traditional Chinese Medicine in diabetes care.” The American Journal of Chinese Medicine. [Cited by 65]
Zhou, L. et al. (2016). “GIP and its metabolic effects in endocrine disorders.” Journal of Diabetes Research. [Cited by 70]
Zhou, L. et al. (2015). “Neurotransmitter regulation in metabolic diseases.” European Journal of Neuroscience. [Cited by 90]
Conclusion
Dr. Ligang Zhou exemplifies the qualities of an outstanding researcher through his exceptional academic achievements, influential research, innovative contributions, and leadership in endocrinology. With a strong record of publications, patents, and international collaborations, he is highly deserving of the Best Researcher Award. His work continues to shape modern endocrinology and improve patient care worldwide.